Advances in Breast Cancer Research
Notice of Termination and Rescheduling
The American Association for Cancer Research (AACR) has made the difficult decision, after careful consideration and a comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, to terminate the AACR Special Conference on Advances in Breast Cancer Research originally scheduled for October 9-12, 2020, in San Diego, California. A rescheduled meeting is being planned.
We recognize that the new data, exchange of information, and opportunities for collaboration offered by this meeting are highly valued by the breast cancer research community; therefore, we are working to reschedule the conference as soon as possible.
Information on the rescheduled meeting will be sent by email once it becomes available. If you have a room reservation at the Hilton San Diego Bayfront, your cancellation will be accepted at no charge up to 72 hours in advance of your scheduled check-in date; please contact the hotel at (619) 564-3333 to cancel your reservation as soon as possible. Many airlines have adjusted their rebooking and cancellation policies in response to the COVID-19 crisis. Please contact your airline or booking agent directly to cancel your travel arrangements to San Diego.
The AACR deeply appreciates your patience and understanding during this unfortunate situation. If you have any questions, please email [email protected].
Our heartfelt sympathies go out to everyone who has been impacted by this global health crisis. Thank you for your dedication to the AACR and to its mission.
Conference Cochairs
Jason Carroll, Cancer Research UK Cambridge Research Institute, Cambridge, United Kingdom
Jenny C. Chang, Houston Methodist Hospital Cancer Center, Houston, Texas
Jane E. Visvader, Walter & Eliza Hall Institute of Medical Research, Parkville, Australia
Join leading basic, translational, and clinical investigators at the 10th AACR Special Conference on Advances in Breast Cancer Research. This year’s program will once again address basic and translational breast cancer research not typically covered in other breast cancer conferences with a more clinical agenda. Topics will include novel model systems, inflammation and the microenvironment, genomics, heterogeneity, personalized risk and prevention, and future therapies and immuno-oncology.
Professional Educational Grants
Daiichi-Sankyo
Eisai
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
